Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small-molecule SMAC mimetics as new cancer therapeutics
Longchuan Bai, David C. Smith, Shaomeng Wang
Pharmacology & Therapeutics (2014) Vol. 144, Iss. 1, pp. 82-95
Open Access | Times Cited: 188

Showing 26-50 of 188 citing articles:

Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo
Haipeng Liu, Danmei Su, Jinlong Zhang, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 82
Rgd-Mediated Delivery of Small-Molecule Drugs
Sotirios Katsamakas, Theodora Chatzisideri, Savvas Thysiadis, et al.
Future Medicinal Chemistry (2017) Vol. 9, Iss. 6, pp. 579-604
Closed Access | Times Cited: 76
A General Strategy for Discovery of Inhibitors and Activators of RING and U-box E3 Ligases with Ubiquitin Variants
Mads Gabrielsen, Lori Buetow, Mark A. Nakasone, et al.
Molecular Cell (2017) Vol. 68, Iss. 2, pp. 456-470.e10
Open Access | Times Cited: 69
Landscape review of current HIV ‘kick and kill’ cure research - some kicking, not enough killing
Kristian Thorlund, Marc S. Horwitz, Brian T. Fife, et al.
BMC Infectious Diseases (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 68
Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)
Emiliano Tamanini, Ildiko M. Buck, Gianni Chessari, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 11, pp. 4611-4625
Closed Access | Times Cited: 66
XIAP’s Profile in Human Cancer
Huailu Tu, Max Costa
Biomolecules (2020) Vol. 10, Iss. 11, pp. 1493-1493
Open Access | Times Cited: 62
Structures of BIRC6-client complexes provide a mechanism of SMAC-mediated release of caspases
Moritz Hunkeler, Cyrus Y Jin, Eric S. Fischer
Science (2023) Vol. 379, Iss. 6637, pp. 1105-1111
Open Access | Times Cited: 22
The GSTP1/MAPKs/BIM/SMAC modulatory actions of nitazoxanide: Bioinformatics and experimental evidence in subcutaneous solid Ehrlich carcinoma-inoculated mice
Samar Imbaby, Shereen E. Elkholy, Salwa Faisal, et al.
Life Sciences (2023) Vol. 319, pp. 121496-121496
Closed Access | Times Cited: 18
Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition
Hyeonji Yoo, Yeonjin Kim, Jinseong Kim, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 3994-3994
Open Access | Times Cited: 7
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 7
USP11-dependent selective cIAP2 deubiquitylation and stabilization determine sensitivity to Smac mimetics
Eun‐Woo Lee, Dawon Seong, Jun Hye Seo, et al.
Cell Death and Differentiation (2015) Vol. 22, Iss. 9, pp. 1463-1476
Open Access | Times Cited: 62
ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth
George A. Ward, Edward J. Lewis, Jong Sook Ahn, et al.
Molecular Cancer Therapeutics (2018) Vol. 17, Iss. 7, pp. 1381-1391
Open Access | Times Cited: 58
XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells
Jiao Ji, Yan Yu, Zhi‐Ling Li, et al.
Theranostics (2018) Vol. 8, Iss. 6, pp. 1494-1510
Open Access | Times Cited: 52
MK2–TNF–Signaling Comes Full Circle
Manoj B. Menon, Matthias Gaestel
Trends in Biochemical Sciences (2017) Vol. 43, Iss. 3, pp. 170-179
Closed Access | Times Cited: 50
Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness
Hanna Karvonen, Mariliina Arjama, Laura Kaleva, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 9
Open Access | Times Cited: 49
Design, synthesis and biological evaluation of novel α-acyloxy carboxamides via Passerini reaction as caspase 3/7 activators
Mohammed Salah Ayoup, Yasmin Wahby, Hamida Abdel‐Hamid, et al.
European Journal of Medicinal Chemistry (2019) Vol. 168, pp. 340-356
Closed Access | Times Cited: 46
SMAC mimetics and RIPK inhibitors as therapeutics for chronic inflammatory diseases
Simone Jensen, Jakob Benedict Seidelin, Eric C. LaCasse, et al.
Science Signaling (2020) Vol. 13, Iss. 619
Open Access | Times Cited: 46
RIPK2 NODs to XIAP and IBD
Joseph Topal, Mads Gyrd‐Hansen
Seminars in Cell and Developmental Biology (2020) Vol. 109, pp. 144-150
Closed Access | Times Cited: 41
Specific non-genetic IAP-based protein erasers (SNIPERs) as a potential therapeutic strategy
Zonghui Ma, Ji Yu, Yifan Yu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 216, pp. 113247-113247
Closed Access | Times Cited: 40
Cell Survival and Cell Death at the Intersection of Autophagy and Apoptosis: Implications for Current and Future Cancer Therapeutics
Nicole Bata, Nicholas D. P. Cosford
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 6, pp. 1728-1746
Open Access | Times Cited: 39
Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis
Rongchen Dai, Mengfan Liu, Xincheng Xiang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 26
A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1H,2H,3H-pyrrolo[3,2-b]pyridin-1-yl)-2-[(2R,5R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660)
Christopher N. Johnson, Jong Sook Ahn, Ildiko M. Buck, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 16, pp. 7314-7329
Closed Access | Times Cited: 46
Characterization of Somatically‐Eliminated Genes During Development of the Sea Lamprey (Petromyzon marinus)
Stephanie A. Bryant, Joseph R. Herdy, Chris T. Amemiya, et al.
Molecular Biology and Evolution (2016) Vol. 33, Iss. 9, pp. 2337-2344
Open Access | Times Cited: 42
Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro
Shin‐ichiro Hattori, Kouki Matsuda, K. Tsuchiya, et al.
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 42
Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway
Jingming XIN, Dewen You, Peter Breslin, et al.
Leukemia (2016) Vol. 31, Iss. 5, pp. 1154-1165
Open Access | Times Cited: 41

Scroll to top